Get the Stockscreener App
5.37
0.74%
-0.04
After Hours:
5.37
Kamada Ltd stock is traded at $5.37, with a volume of 24,762.
It is down -0.74% in the last 24 hours and down -6.61% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$5.41
Open:
$5.41
24h Volume:
24,762
Relative Volume:
0.59
Market Cap:
$308.09M
Revenue:
$142.52M
Net Income/Loss:
$8.28M
P/E Ratio:
67.12
EPS:
0.08
Net Cash Flow:
$-1.54M
1W Performance:
+1.13%
1M Performance:
-6.61%
6M Performance:
-4.28%
1Y Performance:
+0.56%
1-Day Range:
$5.32
$5.41
1-Week Range:
$5.30
$5.4701
52-Week Range:
$4.08
$6.5291
Kamada Ltd Stock (KMDA) Company Profile
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Plasma Therapy Market Advancements Highlighted by Size, Share Analysis And Forecast To 2033 - WhaTech
United States Genetic COPD Market Analysis By Size and Application - Third Eye News
Kamada Ltd expands plasma operations in Texas - Investing.com
Kamada Ltd expands plasma operations in Texas - Investing.com India
Kamada Ltd expands plasma operations in Texas By Investing.com - Investing.com UK
Kamada Opens New Plasma Center in Houston - TipRanks
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston - GlobeNewswire
Kamada expands plasma collection operations in Texas with new site in Houston - Seeking Alpha
Kamada Announces Expansion of Plasma Collection Operations in Texas with the Opening of New Site in Houston - StockTitan
SASTRA signs MoU with Kaynes for semiconductor capacity building - Communications Today
Infra stock jumps 3% after receiving orders worth ₹ 1,003 Cr for multiple projects - Trade Brains
KEC International Boosts Market Presence with Rs 1,003 Crore New Contracts - PUNE.NEWS
India's KEC International rises on 10.03 bln rupee order wins - XM
KEC International shares surge 4% on new orders worth Rs 1,003 crore - Moneycontrol
KEC International has now won nearly 70% of the total orders it received in FY24 - CNBCTV18
Emphysema Treatment Market Innovations Investigated by Size, Share, Analysis, Trends 2024-2033 - WhaTech
'Give me my money', says Kedah winger Norde - New Straits Times
United States Alpha Antitrypsin Deficiency Treatment Market Analysis By Size and Application - Third Eye News
KDA FC Players Display ProfessionalismNafuzi - BERNAMA
Intravenous Immunoglobulin Global Market Size, Trends 2024-2033 - WhaTech
Kamada Ltd. (NASDAQ:KMDA) Shares Bought by Y.D. More Investments Ltd - MarketBeat
Kamada (NASDAQ:KMDA) Stock Price Passes Below 200-Day Moving Average of $5.50 - Defense World
Kamada (NASDAQ:KMDA) Shares Pass Below Two Hundred Day Moving Average of $5.50 - MarketBeat
Human Immunoglobulin Market to Grow by USD 9.69 Billion from 2024-2028, Driven by Increased Plasma Donations, Report Highlights AI's Role in Market TransformationTechnavio - The Malaysian Reserve
Human Immunoglobulin Market to Grow by USD 9.69 Billion from 2024-2028, Driven by Increased Plasma Donations, Report Highlights AI's Role in Market TransformationTechnavio - Lelezard
Human Immunoglobulin Market To Grow By USD 9.69 Billion From 2024-2028, Driven By Increased Plasma Donations, Report Highlights AI's Role In Market Tr... - MENAFN.COM
Global Healthcare & Medical Tourism News - Medical Tourism Magazine
Immunoglobulins Market Innovations Investigated by Rising Trends, Key Leading Players, Trends Analysis, Ind... - WhaTech
Plasma Fractionation Global Market Innovations Investigated by Report 2024: Share and Size 2033 - WhaTech
Simulations Plus And 7 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Kamada (NASDAQ:KMDA) Share Price Passes Below 200-Day Moving Average of $5.53 - MarketBeat
What Daichi Kamada did in 39th minute of Chelsea 1-1 Crystal Palace to leave Oliver Glasner furious - We Are Palace
Alpha 1 Lung Disease Market to Surge at 19.33% CAGR, Reaching $19.93 Billion by 2031 - WhaTech
Alpha 1 Lung Disease Market to Surge at 19.33% CAGR, Reaching $19.93 Billion by 2031 - WhaTech Technology and Markets News
Kamada Ltd. (KMDA): A Cheap Pharmaceutical Stock to Buy According to Short Sellers - MSN
How To Trade (KMDA) - Stock Traders Daily
Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Advancements Highlighted by Size, Share Analysis... - WhaTech
Kamada Ltd. (KMDA): A Cheap Pharmaceutical Stock to Buy According to Short Sellers - Insider Monkey
Kamada Ltd. (KMDA): A Cheap Pharmaceutical Stock to Buy According to Short Sellers - Yahoo Finance
10 Cheap Pharmaceutical Stocks to Buy According to Short Sellers - Insider Monkey
Kamada (NASDAQ:KMDA) Rating Lowered to Buy at StockNews.com - MarketBeat
Kamada (NASDAQ:KMDA) Cut to Buy at StockNews.com - Defense World
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - Yahoo Finance UK
Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - WDRB
Monolithic Power Systems And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity - Via News Agency
Q3 2024 Earnings Forecast for Kamada Ltd. Issued By Zacks Small Cap (NASDAQ:KMDA) - MarketBeat
Zacks Small Cap Weighs in on Kamada Ltd.’s Q3 2024 Earnings (NASDAQ:KMDA) - Defense World
Kamada (NASDAQ:KMDA) Upgraded by StockNews.com to Strong-Buy - Defense World
Kamada (NASDAQ:KMDA) Lifted to "Strong-Buy" at StockNews.com - MarketBeat
HC Wainwright Brokers Raise Earnings Estimates for Kamada Ltd. (NASDAQ:KMDA) - MarketBeat
KMDA: Revenues Up 13% YoY; Adjusted EBITDA Up 51% YoY… - Zacks Small Cap Research
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):